Flosonics Medical Among Winners of the Vale COVID-19 Challenge

Flosonics.png

Sudbury-based Flosonics Medical is one of the 11 winners of the Vale COVID-19 challenge to help move solutions to market. The competition was seeking low to zero-cost solutions that could be deployed to the end-user within 15 days for their approval date.

Flosonics developed a wearable, wireless, single-use monitor, which allows clinicians access critical information about a COVID-19 patient’s cardiovascular state remotely via Bluetooth.

Previous
Previous

VBI Vaccines Secures $50M Debt Financing from K2 HealthVentures

Next
Next

OBIO Announces Early Adopter Health Network Call for Applications to Address COVID-19